BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 23629599)

  • 1. The acid pocket: a target for treatment in reflux disease?
    Kahrilas PJ; McColl K; Fox M; O'Rourke L; Sifrim D; Smout AJ; Boeckxstaens G
    Am J Gastroenterol; 2013 Jul; 108(7):1058-64. PubMed ID: 23629599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acid pocket, hiatus hernia and acid reflux.
    McColl KE; Clarke A; Seenan J
    Gut; 2010 Apr; 59(4):430-1. PubMed ID: 20332515
    [No Abstract]   [Full Text] [Related]  

  • 3. [The acid pocket as the pathogenic basis and therapeutic target in gastroesophageal reflux disease].
    Bordin DS
    Ter Arkh; 2014; 86(2):76-81. PubMed ID: 24772513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The position of the acid pocket as a major risk factor for acidic reflux in healthy subjects and patients with GORD.
    Beaumont H; Bennink RJ; de Jong J; Boeckxstaens GE
    Gut; 2010 Apr; 59(4):441-51. PubMed ID: 19651625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An alginate-antacid formulation localizes to the acid pocket to reduce acid reflux in patients with gastroesophageal reflux disease.
    Rohof WO; Bennink RJ; Smout AJ; Thomas E; Boeckxstaens GE
    Clin Gastroenterol Hepatol; 2013 Dec; 11(12):1585-91; quiz e90. PubMed ID: 23669304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Update on gastroesophageal reflux disease].
    Serra Pueyo J
    Gastroenterol Hepatol; 2014 Feb; 37(2):73-82. PubMed ID: 24355558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe reflux disease is associated with an enlarged unbuffered proximal gastric acid pocket.
    Clarke AT; Wirz AA; Manning JJ; Ballantyne SA; Alcorn DJ; McColl KE
    Gut; 2008 Mar; 57(3):292-7. PubMed ID: 17272648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of alginate in patients with GERD hiatal hernia matters.
    Vardar R; Keskin M; Valitova E; Bayrakci B; Yildirim E; Bor S
    Dis Esophagus; 2017 Oct; 30(10):1-7. PubMed ID: 28859383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Volume, distribution and acidity of gastric secretion on and off proton pump inhibitor treatment: a randomized double-blind controlled study in patients with gastro-esophageal reflux disease (GERD) and healthy subjects.
    Steingoetter A; Sauter M; Curcic J; Liu D; Menne D; Fried M; Fox M; Schwizer W
    BMC Gastroenterol; 2015 Sep; 15():111. PubMed ID: 26328588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gaviscon Double Action Liquid (antacid & alginate) is more effective than antacid in controlling post-prandial oesophageal acid exposure in GERD patients: a double-blind crossover study.
    De Ruigh A; Roman S; Chen J; Pandolfino JE; Kahrilas PJ
    Aliment Pharmacol Ther; 2014 Sep; 40(5):531-7. PubMed ID: 25041141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of the Acid Pocket in Gastroesophageal Reflux Disease.
    Mitchell DR; Derakhshan MH; Robertson EV; McColl KE
    J Clin Gastroenterol; 2016 Feb; 50(2):111-9. PubMed ID: 26535479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomised clinical trial: the effectiveness of Gaviscon Advance vs non-alginate antacid in suppression of acid pocket and post-prandial reflux in obese individuals after late-night supper.
    Deraman MA; Abdul Hafidz MI; Lawenko RM; Ma ZF; Wong MS; Coyle C; Lee YY
    Aliment Pharmacol Ther; 2020 Jun; 51(11):1014-1021. PubMed ID: 32343001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An alginate-antacid formulation (Gaviscon Double Action Liquid) can eliminate or displace the postprandial 'acid pocket' in symptomatic GERD patients.
    Kwiatek MA; Roman S; Fareeduddin A; Pandolfino JE; Kahrilas PJ
    Aliment Pharmacol Ther; 2011 Jul; 34(1):59-66. PubMed ID: 21535446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The acid pocket - a novel target for the treatment of gastro-esophageal reflux disease].
    Sauter M; Fox MR
    Z Gastroenterol; 2018 Oct; 56(10):1276-1282. PubMed ID: 30304750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcardial 24-h wireless pH monitoring in gastroesophageal reflux disease patients with and without hiatal hernia compared with healthy subjects.
    Grigolon A; Cantú P; Bravi I; Caparello C; Penagini R
    Am J Gastroenterol; 2009 Nov; 104(11):2714-20. PubMed ID: 19638965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acidity surrounding the squamocolumnar junction in GERD patients: "acid pocket" versus "acid film".
    Pandolfino JE; Zhang Q; Ghosh SK; Post J; Kwiatek M; Kahrilas PJ
    Am J Gastroenterol; 2007 Dec; 102(12):2633-41. PubMed ID: 17714553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of azithromycin on acid reflux, hiatus hernia and proximal acid pocket in the postprandial period.
    Rohof WO; Bennink RJ; de Ruigh AA; Hirsch DP; Zwinderman AH; Boeckxstaens GE
    Gut; 2012 Dec; 61(12):1670-7. PubMed ID: 22267599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of hiatus hernia in GERD.
    Kahrilas PJ
    Yale J Biol Med; 1999; 72(2-3):101-11. PubMed ID: 10780571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-prandial reflux suppression by a raft-forming alginate (Gaviscon Advance) compared to a simple antacid documented by magnetic resonance imaging and pH-impedance monitoring: mechanistic assessment in healthy volunteers and randomised, controlled, double-blind study in reflux patients.
    Sweis R; Kaufman E; Anggiansah A; Wong T; Dettmar P; Fried M; Schwizer W; Avvari RK; Pal A; Fox M
    Aliment Pharmacol Ther; 2013 Jun; 37(11):1093-102. PubMed ID: 23600790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of proximal gastric volume on hiatal hernia.
    Scheffer RC; Bredenoord AJ; Hebbard GS; Smout AJ; Samsom M
    Neurogastroenterol Motil; 2010 May; 22(5):552-6, e120. PubMed ID: 20105278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.